Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 86
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06818955 | Orlistat Overcoming Third-generation EGFR-TKI Resistance | ||
| NCT06810492 | The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment | ||
| NCT03210064 | Clinical Study of Apatinib and 5-Fu Combination Regimen to Treat Advanced Colorectal Cancer Patients | ||
| NCT05021328 | Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC | ||
| NCT07264998 | Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without Diarrhea | ||
| NCT01863303 | Epidemiological Study of Colorectal Cancer in WuHan | ||
| NCT05105945 | Clinical Study on the Efficacy of Single-port Inflatable Mediastinoscopy Combined With Laparoscopic-assisted Small Incision Surgery and Thoracoscopy Combined With Laparoscopic Surgery for Radical Esophagectomy | ||
| NCT06401005 | SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC) | ||
| NCT02605265 | Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1 | ||
| NCT07405346 | A Trial for Advanced Leiomyosarcoma With Human Organoid-guided Personalized Efficacy | ||
| NCT07841210 | Fosrolapitant and Palonosetron for Highly Emetogenic ADC-Induced Nausea and Vomiting in Solid Tumors | ||
| NCT07130643 | Efficacy and Safety of CDK4/6 Inhibitors Combined With Endocrine Therapy in HR+/HER2- Neoadjuvant Therapy for Early Breast Cancer | ||
| NCT03230708 | Clinical Study of Autologous Erythrocytes Derived MPs Packaging MTX Peritoneal Perfusion to Treat Malignant Ascites | ||
| NCT06050109 | The Benefits of Continued Use of Ovarian Function Suppression After 5 Years | ||
| NCT05476965 | Selected De-escalation Radiotherapy for Postoperative Head and Neck Squamous Cell Carcinoma | ||
| NCT06712524 | Effect of Different Surgical Approaches of Granulomatous Mastitis | ||
| NCT01271439 | Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal Carcinoma | ||
| NCT01899547 | Laparoscopy-Assisted Surgery for Carcinoma of the Low Rectum | ||
| NCT02562599 | Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin | ||
| NCT05044871 | Biomarker-driven Targeted Therapy in Patients With Recurrent Platinum-resistant Epithelial Ovarian Cancer | ||
| NCT06402435 | SBRT, Chemotherapy, and AK112 Neoadjuvant Therapy for Luminal-type Breast Cancer | ||
| NCT05372198 | Surufatinib With or Wothout Immunotherapy for Advanced Colorectal Cancer in Later Line | ||
| NCT07188857 | Study on the Relationship Between Opioid Drugs and the Therapeutic Efficacy of Immunotherapy | ||
| NCT05219851 | The Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors | ||
| NCT03595644 | Maintenance Targeted Therapy With or Without Stereotactic Body Radiation Therapy for Stage IV Non-small Cell Lung Cancer | ||
| NCT07002346 | INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma | ||
| NCT07541001 | PRL3-Zumab in Patients With Advanced Solid Tumors | ||
| NCT05533892 | Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Advanced HCC | ||
| NCT03716245 | Clinical Significance of Supraclavicular Lymph Node Dissection for Breast Cancer | ||
| NCT05342792 | Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma | ||
| NCT04125849 | Mediastinoscopy-assisted Transhiatal Esophagectomy Versus Thoraco-laparoscopic Esophagectomy for Esophageal Cancer | ||
| NCT05565014 | Safety and Efficacy Study of Virus Activated Killer Immune Cells (VAK) for Malignant Pleural and Peritoneal Effusion | ||
| NCT02288195 | CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients | ||
| NCT06224842 | Clinical Study of Mitoxantrone Liposome and Azacitidine in the Treatment of R/R AITL | ||
| NCT05431621 | Establishment of Molecular Classification Models for Early Diagnosis of Digestive System Cancers | ||
| NCT07263347 | DIEP Flap Breast Reconstruction: Perioperative Biomarkers and Outcomes | ||
| NCT06470256 | Palliative Hepatectomy Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma | ||
| NCT06440018 | INSPIRE: a Multi-Cancer Early Detection Study | ||
| NCT02094638 | Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study | ||
| NCT03482089 | Cystoprostatectomy Versus Radiotherapy Combined With ADT for the Treatment of cT4 Prostate Cancer With Bladder Invasion | ||
| NCT03801200 | Apatinib Combined With Radiotherapy in Patient With BM From Drive Gene Negative NSCLC | ||
| NCT05780372 | Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma | ||
| NCT05661357 | Disitamab Vedotin Combined With Fruquintinib for mCRC With HER2 Expression | ||
| NCT06080880 | Ondanstron Weekly vs Every 3 Weeks for Prevention of Nausea and Vomiting Induced by Chemotherapy Combined With PD-1 Blockade | ||
| NCT06329206 | A Phase Ia/Ib Study of GH2616 Tablet in Subjects With Advanced Solid Tumors | ||
| NCT06279104 | A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary | ||
| NCT06020430 | Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy | ||
| NCT03663153 | SEMA4C as a Relapse Biomarker in Breast Cancer | ||
| NCT03662633 | Diagnosis Value of SEMA4C in Breast Cancer | ||
| NCT05520801 | Primary Hepatobiliary Cancer Cohort of Central China |
